| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 66.5 | - | - | - | - | - | - | 1 | - | - | 67.5 |
| 10.5 | - | - | - | - | - | - | - | - | - | 10.5 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 832 |
| 204 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 444 |
| 118.5 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AME(R) | 1,664 | 57.7% | -2.03 | 408 | 58.1% |
| PLP(R) | 710 | 24.6% | -2.08 | 168 | 23.9% |
| CentralBrain-unspecified | 178 | 6.2% | -1.37 | 69 | 9.8% |
| Optic-unspecified(R) | 200 | 6.9% | -2.47 | 36 | 5.1% |
| ME(R) | 134 | 4.6% | -2.67 | 21 | 3.0% |
| upstream partner | # | NT | conns aMe1 | % In | CV |
|---|---|---|---|---|---|
| aMe4 (R) | 9 | ACh | 204.5 | 14.4% | 0.5 |
| MeVP1 (R) | 33 | ACh | 170 | 12.0% | 1.2 |
| aMe5 (R) | 15 | ACh | 111 | 7.8% | 0.9 |
| aMe6b (R) | 1 | ACh | 95.5 | 6.7% | 0.0 |
| aMe1 (R) | 2 | GABA | 82 | 5.8% | 0.2 |
| aMe6c (R) | 1 | Glu | 81 | 5.7% | 0.0 |
| aMe2 (R) | 4 | Glu | 79.5 | 5.6% | 0.5 |
| MeVPMe12 (L) | 2 | ACh | 77 | 5.4% | 0.1 |
| aMe3 (R) | 1 | Glu | 57 | 4.0% | 0.0 |
| aMe6a (R) | 1 | ACh | 51 | 3.6% | 0.0 |
| aMe10 (L) | 1 | ACh | 46 | 3.2% | 0.0 |
| aMe30 (R) | 2 | Glu | 42.5 | 3.0% | 0.0 |
| MeVP49 (R) | 1 | Glu | 29 | 2.0% | 0.0 |
| MeVC20 (R) | 2 | Glu | 29 | 2.0% | 0.2 |
| LoVC3 (L) | 1 | GABA | 28 | 2.0% | 0.0 |
| MeVP11 (R) | 17 | ACh | 25.5 | 1.8% | 1.2 |
| aMe22 (R) | 1 | Glu | 23 | 1.6% | 0.0 |
| MeVCMe1 (L) | 2 | ACh | 20 | 1.4% | 0.7 |
| MeVCMe1 (R) | 2 | ACh | 17 | 1.2% | 0.4 |
| aMe12 (R) | 2 | ACh | 14 | 1.0% | 0.5 |
| SLP250 (R) | 1 | Glu | 12 | 0.8% | 0.0 |
| aMe10 (R) | 2 | ACh | 10.5 | 0.7% | 0.1 |
| aMe24 (R) | 1 | Glu | 10 | 0.7% | 0.0 |
| OA-AL2i3 (R) | 2 | OA | 10 | 0.7% | 0.1 |
| PLP021 (R) | 2 | ACh | 7 | 0.5% | 0.3 |
| HBeyelet (R) | 3 | HA | 6 | 0.4% | 0.5 |
| MeVPaMe2 (L) | 1 | Glu | 5.5 | 0.4% | 0.0 |
| aMe12 (L) | 2 | ACh | 5 | 0.4% | 0.4 |
| MeVPMe3 (L) | 1 | Glu | 4.5 | 0.3% | 0.0 |
| PLP_TBD1 (R) | 1 | Glu | 4.5 | 0.3% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 4.5 | 0.3% | 0.0 |
| PLP211 (R) | 1 | unc | 4 | 0.3% | 0.0 |
| MeLo1 (R) | 6 | ACh | 4 | 0.3% | 0.4 |
| L3 (R) | 3 | ACh | 3.5 | 0.2% | 0.5 |
| SLP249 (R) | 2 | Glu | 3 | 0.2% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 2.5 | 0.2% | 0.0 |
| PLP080 (R) | 1 | Glu | 2.5 | 0.2% | 0.0 |
| MeVP25 (R) | 1 | ACh | 2.5 | 0.2% | 0.0 |
| OCG02c (L) | 2 | ACh | 2.5 | 0.2% | 0.2 |
| MeVPMe4 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| aMe23 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeVP31 (R) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| MeVP38 (R) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| Cm35 (R) | 1 | GABA | 1.5 | 0.1% | 0.0 |
| MeVC3 (L) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| OCG02c (R) | 2 | ACh | 1.5 | 0.1% | 0.3 |
| Tm5c (R) | 3 | Glu | 1.5 | 0.1% | 0.0 |
| DNp32 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| MeVP22 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| l-LNv (L) | 1 | unc | 1 | 0.1% | 0.0 |
| CL357 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| Mi15 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP21 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVC21 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| aMe_TBD1 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm20 (R) | 2 | GABA | 1 | 0.1% | 0.0 |
| aMe17c (R) | 2 | Glu | 1 | 0.1% | 0.0 |
| Dm9 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| AOTU058 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| CB3249 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeLo6 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm23 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| SMP340 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP30 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| DN1a (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| l-LNv (R) | 1 | unc | 0.5 | 0.0% | 0.0 |
| SMP091 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| LoVP37 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| PLP261 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LHPD1b1 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| DNpe053 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVC24 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP9 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LoVCLo2 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| MeVC22 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPaMe1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| OA-AL2i4 (R) | 1 | OA | 0.5 | 0.0% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 0.5 | 0.0% | 0.0 |
| downstream partner | # | NT | conns aMe1 | % Out | CV |
|---|---|---|---|---|---|
| aMe17c (R) | 2 | Glu | 149 | 11.7% | 0.1 |
| CL125 (R) | 2 | Glu | 111.5 | 8.7% | 0.1 |
| Lat2 (R) | 2 | unc | 102.5 | 8.0% | 0.1 |
| aMe1 (R) | 2 | GABA | 82 | 6.4% | 0.2 |
| SLP250 (R) | 1 | Glu | 68 | 5.3% | 0.0 |
| Lat1 (R) | 4 | unc | 61 | 4.8% | 0.3 |
| 5thsLNv_LNd6 (R) | 2 | ACh | 57 | 4.5% | 0.2 |
| PLP211 (R) | 1 | unc | 53.5 | 4.2% | 0.0 |
| aMe6b (R) | 1 | ACh | 52.5 | 4.1% | 0.0 |
| aMe_TBD1 (R) | 1 | GABA | 52 | 4.1% | 0.0 |
| MeVP11 (R) | 20 | ACh | 44 | 3.5% | 0.9 |
| SLP249 (R) | 2 | Glu | 39 | 3.1% | 0.1 |
| aMe17e (R) | 1 | Glu | 33.5 | 2.6% | 0.0 |
| aMe20 (R) | 1 | ACh | 32.5 | 2.5% | 0.0 |
| MeVP63 (R) | 1 | GABA | 26.5 | 2.1% | 0.0 |
| SMP200 (R) | 1 | Glu | 24 | 1.9% | 0.0 |
| aMe3 (R) | 1 | Glu | 20.5 | 1.6% | 0.0 |
| MeVC22 (R) | 2 | Glu | 17.5 | 1.4% | 0.0 |
| aMe15 (R) | 1 | ACh | 16.5 | 1.3% | 0.0 |
| DNpe021 (R) | 1 | ACh | 16.5 | 1.3% | 0.0 |
| l-LNv (R) | 4 | unc | 15 | 1.2% | 0.9 |
| LoVP96 (R) | 1 | Glu | 13 | 1.0% | 0.0 |
| SMP217 (R) | 2 | Glu | 10.5 | 0.8% | 0.8 |
| aMe8 (R) | 2 | unc | 9 | 0.7% | 0.1 |
| AOTU055 (R) | 2 | GABA | 8.5 | 0.7% | 0.5 |
| aMe6c (R) | 1 | Glu | 8 | 0.6% | 0.0 |
| LT58 (R) | 1 | Glu | 7.5 | 0.6% | 0.0 |
| aMe30 (R) | 2 | Glu | 7.5 | 0.6% | 0.1 |
| aMe26 (R) | 3 | ACh | 6.5 | 0.5% | 0.6 |
| aMe10 (R) | 2 | ACh | 6.5 | 0.5% | 0.2 |
| MeVPaMe2 (L) | 1 | Glu | 6 | 0.5% | 0.0 |
| aMe6a (R) | 1 | ACh | 5.5 | 0.4% | 0.0 |
| OCG02c (L) | 2 | ACh | 5 | 0.4% | 0.2 |
| MeVPaMe1 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| LoVP53 (R) | 1 | ACh | 4 | 0.3% | 0.0 |
| aMe2 (R) | 3 | Glu | 3.5 | 0.3% | 0.5 |
| Dm20 (R) | 4 | Glu | 3.5 | 0.3% | 0.2 |
| Tm5c (R) | 7 | Glu | 3.5 | 0.3% | 0.0 |
| MeLo2 (R) | 6 | ACh | 3.5 | 0.3% | 0.3 |
| MeLo6 (R) | 2 | ACh | 3 | 0.2% | 0.7 |
| aMe10 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| Lat5 (R) | 1 | unc | 3 | 0.2% | 0.0 |
| CB3141 (R) | 1 | Glu | 3 | 0.2% | 0.0 |
| Tm16 (R) | 2 | ACh | 3 | 0.2% | 0.7 |
| aMe5 (R) | 3 | ACh | 3 | 0.2% | 0.4 |
| PLP144 (R) | 1 | GABA | 2.5 | 0.2% | 0.0 |
| aMe4 (R) | 3 | ACh | 2.5 | 0.2% | 0.6 |
| MeVPaMe1 (R) | 1 | ACh | 2.5 | 0.2% | 0.0 |
| PS272 (R) | 2 | ACh | 2.5 | 0.2% | 0.6 |
| aMe22 (R) | 1 | Glu | 2.5 | 0.2% | 0.0 |
| aMe12 (R) | 2 | ACh | 2.5 | 0.2% | 0.2 |
| aMe17a (R) | 1 | unc | 2 | 0.2% | 0.0 |
| LoVP50 (R) | 2 | ACh | 2 | 0.2% | 0.5 |
| Lat3 (R) | 3 | unc | 2 | 0.2% | 0.4 |
| Mi18 (R) | 2 | GABA | 2 | 0.2% | 0.5 |
| TmY5a (R) | 2 | Glu | 2 | 0.2% | 0.0 |
| MeVP1 (R) | 3 | ACh | 2 | 0.2% | 0.4 |
| OCG02c (R) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| aMe24 (R) | 1 | Glu | 1.5 | 0.1% | 0.0 |
| aMe13 (R) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| PLP121 (R) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| MeVPMe12 (L) | 2 | ACh | 1.5 | 0.1% | 0.3 |
| Li20 (R) | 2 | Glu | 1.5 | 0.1% | 0.3 |
| Cm20 (R) | 3 | GABA | 1.5 | 0.1% | 0.0 |
| AOTU054 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVPMe12 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP174 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP_TBD1 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Pm8 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVC23 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Pm12 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Lawf1 (R) | 2 | ACh | 1 | 0.1% | 0.0 |
| aMe23 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Mi19 (R) | 2 | unc | 1 | 0.1% | 0.0 |
| MeLo1 (R) | 2 | ACh | 1 | 0.1% | 0.0 |
| LoVP38 (R) | 2 | Glu | 1 | 0.1% | 0.0 |
| MeVC20 (R) | 2 | Glu | 1 | 0.1% | 0.0 |
| PLP074 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| LoVP83 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| DNpe053 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP62 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP30 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| l-LNv (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| MeVCMe1 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Dm10 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| Tm37 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Tm4 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CB4091 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| TmY13 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Dm9 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| WED094 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP3 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| T1 (R) | 1 | HA | 0.5 | 0.0% | 0.0 |
| CB3001 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Lat4 (R) | 1 | unc | 0.5 | 0.0% | 0.0 |
| Dm1 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP17 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LoVP30 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LoVP46 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| AOTU045 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LoVP64 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| aMe17b (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| LT88 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| PLP131 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeVC21 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP29 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP49 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| AVLP531 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVC25 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |